These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35273524)

  • 1. Cortical Thickness Predicts Response Following 2 Weeks of SSRI Regimen in First-Episode, Drug-Naive Major Depressive Disorder: An MRI Study.
    Wu P; Zhang A; Sun N; Lei L; Liu P; Wang Y; Li H; Yang C; Zhang K
    Front Psychiatry; 2021; 12():751756. PubMed ID: 35273524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder.
    Zhang A; Wang X; Li J; Jing L; Hu X; Li H; Yang C; Zhang K; Sun N
    Front Neurosci; 2022; 16():831278. PubMed ID: 35250466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain Imaging Study on the Pathogenesis of Depression & Therapeutic Effect of Selective Serotonin Reuptake Inhibitors.
    Meng Q; Zhang A; Cao X; Sun N; Li X; Zhang Y; Wang Y
    Psychiatry Investig; 2020 Jul; 17(7):688-694. PubMed ID: 32631032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased cortical thickness of left premotor cortex as a treatment predictor in major depressive disorder.
    Liu X; Hou Z; Yin Y; Xie C; Zhang H; Zhang H; Zhang Z; Yuan Y
    Brain Imaging Behav; 2021 Jun; 15(3):1420-1426. PubMed ID: 32710337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saliva levels of 3-methoxy-4-hydroxyphenylglycol and clinical efficacy of mirtazapine or selective serotonin reuptake inhibitors in patients with major depression.
    Egami M; Imamura Y; Nabeta H; Mizoguchi Y; Yamada S
    Hum Psychopharmacol; 2013 Jan; 28(1):7-14. PubMed ID: 23124792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of early improvement of major depressive disorder to antidepressant medication in adolescents with radiomics analysis after ComBat harmonization based on multiscale structural MRI.
    Ma H; Zhang D; Wang Y; Ding Y; Yang J; Li K
    BMC Psychiatry; 2023 Jun; 23(1):466. PubMed ID: 37365541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functional connectivity of the middle frontal cortex predicts ketamine's outcome in major depressive disorder.
    Zhang F; Wang C; Lan X; Li W; Fu L; Ye Y; Liu H; Wu K; Zhou Y; Ning Y
    Front Neurosci; 2022; 16():956056. PubMed ID: 36188452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onset of clinical effects and plasma concentration of fluvoxamine in Japanese patients.
    Katoh Y; Uchida S; Kawai M; Takei N; Mori N; Kawakami J; Kagawa Y; Yamada S; Namiki N; Hashimoto H
    Biol Pharm Bull; 2010; 33(12):1999-2002. PubMed ID: 21139240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
    Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report.
    Suh JS; Minuzzi L; Raamana PR; Davis A; Hall GB; Harris J; Hassel S; Zamyadi M; Arnott SR; Alders GL; Sassi RB; Milev R; Lam RW; MacQueen GM; Strother SC; Kennedy SH; Frey BN
    Neuroimage Clin; 2020; 25():102178. PubMed ID: 32036277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EEG microstates as markers of major depressive disorder and predictors of response to SSRIs therapy.
    Lei L; Liu Z; Zhang Y; Guo M; Liu P; Hu X; Yang C; Zhang A; Sun N; Wang Y; Zhang K
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jun; 116():110514. PubMed ID: 35085607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor analysis of electroacupuncture and selective serotonin reuptake inhibitors for major depressive disorder: an 8-week controlled clinical trial.
    Yang X; Gong W; Ma X; Wang S; Wang X; Guo T; Guo Z; Sun Y; Li J; Zhao B; Tu Y
    Acupunct Med; 2020 Feb; 38(1):45-52. PubMed ID: 31544488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of Sertraline on Serum Cytokine Levels in Adolescents With First-Episode Major Depressive Disorder].
    Xiang JJ; Hong S; Ran LY; Zeng Q; Kong YT; Zhang CY; Liao J; Kuang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):310-315. PubMed ID: 36949691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential predictors for treatment-resistance depression after selective serotonin reuptake inhibitors therapy in Han Chinese: A resting-state functional magnetic resonance imaging study.
    Li Y; Yin Y; Yu Y; Hu X; Liu X; Wu S
    Early Interv Psychiatry; 2024 Feb; ():. PubMed ID: 38320861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desynchronized Functional Activities Between Brain White and Gray Matter in Major Depression Disorder.
    Zhang Y; Kong Y; Liu X; Gao H; Yin Y; Hou Z; Zhang H; Zhang H; Xie C; Zhang Z; Yuan Y
    J Magn Reson Imaging; 2021 May; 53(5):1375-1386. PubMed ID: 33305508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cytokines-based biomarkers in the diagnosis and monitoring of therapeutic response in patients with major depressive disorder.
    Xu Y; Liang J; Sun Y; Zhang Y; Shan F; Ge J; Xia Q
    Int Immunopharmacol; 2023 May; 118():110108. PubMed ID: 37004349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percentage reduction of depression severity versus absolute severity after initial weeks of treatment to predict final response or remission.
    Lin CH; Chen CC; Wang FC; Lane HY
    Psychiatry Clin Neurosci; 2013 May; 67(4):265-72. PubMed ID: 23683158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of gut microbiota and its correlation with hs-CRP and somatic symptoms in first-episode treatment-naive major depressive disorder.
    Liu P; Jing L; Guo F; Xu Y; Cheng J; Liu S; Liu L; Liu Z; Zhang K; Sun N
    J Affect Disord; 2024 Jul; 356():664-671. PubMed ID: 38615845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RELATIONSHIP BETWEEN THE CORTICAL THICKNESS AND SERUM CORTISOL LEVELS IN DRUG-NAÏVE, FIRST-EPISODE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SURFACE-BASED MORPHOMETRIC STUDY.
    Liu X; Kakeda S; Watanabe K; Yoshimura R; Abe O; Ide S; Hayashi K; Katsuki A; Umeno-Nakano W; Watanabe R; Ueda I; Moriya J; Nakamura J; Korogi Y
    Depress Anxiety; 2015 Sep; 32(9):702-8. PubMed ID: 26290363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis.
    Kuga A; Tsuji T; Hayashi S; Matsubara M; Fujikoshi S; Tokuoka H; Yoshikawa A; Escobar R; Tanaka K; Azekawa T
    Neuropsychiatr Dis Treat; 2017; 13():2105-2114. PubMed ID: 28831259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.